Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
0.00%
)
Bitcoin
70,721.18
(
0.29%
)
News Focus
News Focus

Replies to post #148318 on Biotech Values

Replies to #148318 on Biotech Values
icon url

Thurly

09/07/12 11:26 AM

#148320 RE: pcrutch #148318

Chicago reports no imbalances between arms. If balanced, historical data not relevant. 90% of all patients were stage IV. All others were stage III.

MOS data not final. Majority of treatment arm patients still alive.

Lots of data coming out today, though. Trial legit? TBD
icon url

JohnWayne

09/07/12 11:28 AM

#148321 RE: pcrutch #148318

Agreed re: wanting to see the baseline characteristics, but just want to note that DTIC is dacarbazine, whereas the PPHM trial used docetaxel as the comparator.